SCLL - anyone watching, chart please, word is that company has requested GOV funds
29-Mar-2006
Regulation FD Disclosure, Financial Statements and Exhibits
Item 7.01 Regulation FD Disclosure.
The information in this Current Report on Form 8-K, including the exhibits listed in Item 9.01 below, is being furnished, not filed, under Item 7.01 pursuant to Regulation FD.
On March 29, 2006, Dr. James H. Kelly, Chief Executive Officer of the Company, will present data at the Keystone Symposium on Stem Cells in Vancouver. A copy of his presentation is attached to this report as Exhibit 99.2.
While the widespread use of ES cells has been hampered by ethical issues and government funding limitations, Congressional legislation treats fetal tissue differently. The U.S. Department of Health and Human Services has stated that research involving the derivation and use of EG cells may be conducted with Federal support (http://www.hhs.gov/ohrp/humansubjects/guidance/stemcell.pdf).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.